https://bioengineer.org/tb-vaccination-could-be-overall-cost-effective-in-73-of-105-lmics-70-and-produce-economic-benefits-of-us-474-billion-by-2050-per-modelling-study-by-researchers-at-harvard-lshtm-the-who-and-iavi/